Company News

Share this article:

Sanofi-Aventis acquired Laboratorios Kendrick, a Mexican generic manufacturer. Sanofi hopes the purchase will extend its pharmaceutical portfolio in emerging markets. Laboratorios Kendric recorded sales of approximately $35 million in 2008.

 

Genzyme struck a deal with Bayer HealthCare to assume “primary responsibility” for the worldwide commercialization of Campath, a multiple sclerosis treatment. Genzyme also picked up Bayer's cancer drugs Fludara and Leukine, and will buy Bayer's Leukine manufacturing plant, near Seattle, for $75 - $100 million.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters